Patient Guide: A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 125 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04623775
Status: ACTIVE_NOT_RECRUITING
Condition: Non-small Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer
Phase: PHASE2

Find a Study Location Near You

This study is available at 125 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Duarte, California
  • Orange, California
  • New Haven, Connecticut
  • • And 122 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily